SCHEMBL6451780

SCHEMBL6451780

O=C(NCc1ccccc1C(F)(F)F)c1cc(-c2ccccc2)nc2ccccc12

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 3/20 0.69
CYP2C9 P11712 2/20 0.64
ALDH1A1 P00352 5/20 0.61
KDM4E B2RXH2 3/20 0.61
LMNA P02545 3/20 0.60
MAPK1 P28482 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
TP53 P04637 2/20 0.59
HTT P42858 2/20 0.59
NPC1 O15118 1/20 0.59
RAB9A P51151 1/20 0.59
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
POLB P06746 1/20 0.58
TRPV1 Q8NER1 2/20 0.57
CYP3A4 P08684 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6447770 0.84 TACR3 (0.75) TACR3CYP2C9ALDH1A1KDM4ELMNA
SCHEMBL6450086 0.82 TACR3 (1.00) TACR3CYP2C9ALDH1A1KDM4ELMNA
SCHEMBL6448423 0.81 TACR3 (0.70) TACR3CYP2C9ALDH1A1KDM4ELMNA
SCHEMBL931169 0.78 ADORA2A (0.61)
SCHEMBL10391576 0.77 TACR3 (0.76) TACR3ALDH1A1KDM4ELMNAMAPK1
SCHEMBL28806102 0.77 TACR3 (0.83) TACR3CYP2C9ALDH1A1KDM4ELMNA
SCHEMBL14623959 0.75 TACR3 (0.72) TACR3ALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL14133006 0.75 TACR3 (0.72) TACR3ALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL6630664 0.75 TACR3 (0.72) TACR3CYP2C9ALDH1A1KDM4ELMNA
SCHEMBL23722901 0.75 TACR3 (0.72) TACR3ALDH1A1KDM4ELMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517708-A1 COMBINATION TREATMENT FOR DEPRESSION AND ANXIETY BY NK1 AND NK3 ANTAGONISTS Pfizer Products Inc. (US) 2005-03-30 EP disclosed
WO-2004000355-A1 COMBINATION TREATMENT FOR DEPRESSION AND ANXIETY BY NK1 AND NK3 ANTAGONISTS PFIZER PRODUCTS INC. (US) 2003-12-31 WO disclosed